APP and early-onset autosomal dominant Alzheimer disease: Our future studies will determine which type of β-glucans exhibit the best beneficial effect to improve cognitive impairment in a senescence-accelerated mouse prone 8 (SAMP8) mouse model with rapid cognitive decline, APP transgenic mouse models for Alzheimer's disease and high-fat diet-induced obese mice with cognition decline.